A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550mg TID in Subjects with Irritable Bowel Syndrome with Diarrhea (IBS-D)
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study is being conducted to help us learn more about how to help people who have Irritable Bowel Syndrome with diarrhea.
Description
This study is being conducted to help us learn more about how to help people who have Irritable Bowel Syndrome with diarrhea.
Details
| Condition | Irritable Bowel Syndrome |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX2824 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.